BAX
Price
$22.84
Change
-$0.03 (-0.13%)
Updated
Sep 24, 11:47 AM (EDT)
Capitalization
11.74B
36 days until earnings call
SOLV
Price
$72.66
Change
-$0.74 (-1.01%)
Updated
Sep 24, 12:29 PM (EDT)
Capitalization
12.72B
43 days until earnings call
Interact to see
Advertisement

BAX vs SOLV

Header iconBAX vs SOLV Comparison
Open Charts BAX vs SOLVBanner chart's image
Baxter International
Price$22.84
Change-$0.03 (-0.13%)
Volume$2.14K
Capitalization11.74B
Solventum
Price$72.66
Change-$0.74 (-1.01%)
Volume$300
Capitalization12.72B
BAX vs SOLV Comparison Chart in %
Loading...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SOLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAX vs. SOLV commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a Hold and SOLV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (BAX: $22.86 vs. SOLV: $73.39)
Brand notoriety: BAX and SOLV are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BAX: 59% vs. SOLV: 71%
Market capitalization -- BAX: $11.74B vs. SOLV: $12.72B
BAX [@Pharmaceuticals: Other] is valued at $11.74B. SOLV’s [@Pharmaceuticals: Other] market capitalization is $12.72B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $160.51B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAX’s FA Score shows that 2 FA rating(s) are green whileSOLV’s FA Score has 0 green FA rating(s).

  • BAX’s FA Score: 2 green, 3 red.
  • SOLV’s FA Score: 0 green, 5 red.
According to our system of comparison, BAX is a better buy in the long-term than SOLV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAX’s TA Score shows that 4 TA indicator(s) are bullish while SOLV’s TA Score has 6 bullish TA indicator(s).

  • BAX’s TA Score: 4 bullish, 3 bearish.
  • SOLV’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SOLV is a better buy in the short-term than BAX.

Price Growth

BAX (@Pharmaceuticals: Other) experienced а -4.23% price change this week, while SOLV (@Pharmaceuticals: Other) price change was -1.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.28%. For the same industry, the average monthly price growth was -1.82%, and the average quarterly price growth was +9.28%.

Reported Earning Dates

BAX is expected to report earnings on Oct 30, 2025.

SOLV is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.28% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SOLV($12.7B) has a higher market cap than BAX($11.7B). BAX has higher P/E ratio than SOLV: BAX (87.85) vs SOLV (33.67). SOLV YTD gains are higher at: 11.096 vs. BAX (-20.229). SOLV has higher annual earnings (EBITDA): 1.28B vs. BAX (1.04B). BAX has more cash in the bank: 1.69B vs. SOLV (492M). SOLV has less debt than BAX: SOLV (7.82B) vs BAX (9.73B). BAX has higher revenues than SOLV: BAX (10.9B) vs SOLV (8.39B).
BAXSOLVBAX / SOLV
Capitalization11.7B12.7B92%
EBITDA1.04B1.28B81%
Gain YTD-20.22911.096-182%
P/E Ratio87.8533.67261%
Revenue10.9B8.39B130%
Total Cash1.69B492M343%
Total Debt9.73B7.82B124%
FUNDAMENTALS RATINGS
BAX: Fundamental Ratings
BAX
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
29
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BAXSOLV
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
50%
Momentum
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 20 days ago
52%
Bullish Trend 17 days ago
63%
Declines
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 10 days ago
55%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SOLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GLNK28.330.17
+0.60%
Grayscale Chainlink Trust (LINK)
HERD42.490.03
+0.07%
Pacer Cash Cows Fund of Funds ETF
PFXF17.91-0.01
-0.06%
VanEck Pref Secs ex Fincls ETF
GFEB40.43-0.09
-0.21%
FT Vest U.S. Eq Mod Buffr ETF - Feb
RYLG22.62-0.07
-0.31%
Global X Russell 2000 Cov Cl & Gr ETF

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been loosely correlated with ALGN. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if BAX jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
+0.22%
ALGN - BAX
60%
Loosely correlated
-1.66%
LUNG - BAX
53%
Loosely correlated
-1.09%
STE - BAX
51%
Loosely correlated
-0.19%
SYK - BAX
51%
Loosely correlated
-1.24%
SOLV - BAX
50%
Loosely correlated
-0.50%
More

SOLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLV has been loosely correlated with NVST. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLV jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLV
1D Price
Change %
SOLV100%
-0.50%
NVST - SOLV
55%
Loosely correlated
-0.24%
BAX - SOLV
50%
Loosely correlated
+0.22%
RMD - SOLV
48%
Loosely correlated
+0.44%
AZTA - SOLV
47%
Loosely correlated
-3.73%
ALC - SOLV
46%
Loosely correlated
-3.07%
More